What it sells
Developing early cancer detection technology based on RNA modification analysis.
Business model breakdown
Workflow: what inputs become what output?
Develops RNA-modification-based screening to detect cancer at "stage 0", focused on pancreatic cancer; still in R&D (seed round raised 2026-08-28).
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-08-28 | Seed | — | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.